
- Tissue
- Liver
- Disease
- Hepatocellular carcinoma
- Metastatic site
- Ascites
- Synonyms
- Yoshida AH-130, Yoshida AH130, AH130, AH 130, AH-130 Yoshida, AH130-TC, AH130/P
Documents
AH-130
Cell line · Product number 500412
Yoshida et al. have established the ascites hepatoma by converting the aminoazo dyeinduced hepatoma of the rat into the ascetic form (Yoshida 1956). AH-130 i...
Recommended (freshest lot)
01General information
- Description
- Yoshida et al. have established the ascites hepatoma by converting the aminoazo dyeinduced hepatoma of the rat into the ascetic form (Yoshida 1956). AH-130 is a strain of ascites hepatoma composed of free tumor cells, only small islands of tumor islets are present. The cell line described here was established as in vitro cell culture from this Yoshida AH-130 strain of ascites hepatoma.
- Tissue
- Liver
- Disease
- Hepatocellular carcinoma
- Metastatic site
- Ascites
- Applications
- Hepatocellular carcinoma research; rat liver tumor biology; Yoshida ascites hepatoma model; drug sensitivity and cytotoxicity testing; adenovirus susceptibility studies; preclinical liver cancer modeling in Sprague-Dawley rats; adherent/suspension tumor biology
- Synonyms
- Yoshida AH-130
- Yoshida AH130
- AH130
- AH 130
- AH-130 Yoshida
- AH130-TC
- AH130/P
02Classification
- Organism
- Rat
- Sex
- Unspecified
- Growth properties
- Adherent and suspension
- GMO status
- Non-GMO
- GMO status details
- No genetic modification; transplantable rat ascites hepatoma derived from aminoazo dye-induced primary hepatoma by Yoshida (1956)
- Biosafety level
- 1
03Characteristics
- Morphology
- Round suspension cells, triangular adherent cells
- Cell type
- Hepatocellular carcinoma cells (hepatocarcinoma)
- Tumourigenic
- Yes, in Wistar and other strains.
- Doubling time
- approx. 18 to 24 hours (fast growing; BD=Fast confirmed)
04Identifiers
- Citation
- AH-130 (Cytion catalog number 500412)
- NCBI TaxID
- 10116
- Cellosaurus
- CVCL_4367
05Expression and susceptibility
- Viruses
- RAP-test negative. .
- Virus susceptibility
- Highly sensitive to human adenoviruses
06Handling and culture
- Culture medium
- DMEM:Ham's F12 (1:1), w: 3.1 g/L Glucose, w: 2.5 mM L-Glutamine, w: 15 mM HEPES, w: 0.5 mM Sodium pyruvate, w: 1.2 g/L NaHCO3 (Cytion article number 820400a)
- Incubation atmosphere
37°C, 5% CO2, humidified atmosphere.
- Supplements
- Supplement the medium with 10% FBS
- Dissociation reagent
- Accutase
- Subculturing
- Gather the suspension cells in a 15 ml tube and gently wash the adherent cells with PBS lacking calcium and magnesium (use 3-5 ml for T25 flasks and 5-10 ml for T75 flasks). Apply Accutase (1-2 ml for T25 flasks, 2.5 ml for T75 flasks) ensuring full coverage of the cell layer. Allow the cells to incubate at room temperature for 10 minutes. Following incubation, combine and centrifuge both the suspension and adherent cells. After centrifugation, carefully resuspend the cell pellet and transfer the cell suspension into new flasks containing fresh medium.
- Split ratio
- 1 to 3
- Seeding density
- 2 x 104 cells/cm2
- Fluid renewal
- Every 3 to 5 days
- Post-thaw recovery
- Fast
- Thawing and culturing
Confirm that the vial remains deeply frozen upon delivery, as cells are shipped on dry ice to maintain optimal temperatures during transit.
Upon receipt, either store the cryovial immediately at temperatures below -150°C to ensure the preservation of cellular integrity, or proceed to step 3 if immediate culturing is required.
For immediate culturing, swiftly thaw the vial by immersing it in a 37°C water bath with clean water and an antimicrobial agent, agitating gently for 40-60 seconds until a small ice clump remains.
Perform all subsequent steps under sterile conditions in a flow hood, disinfecting the cryovial with 70% ethanol before opening.
Carefully open the disinfected vial and transfer the cell suspension into a 15 ml centrifuge tube containing 8 ml of room-temperature culture medium, mixing gently.
Centrifuge the mixture at 300 x g for 3 minutes to separate the cells and carefully discard the supernatant containing residual freezing medium.
Gently resuspend the cell pellet in 10 ml of fresh culture medium. For adherent cells, divide the suspension between two T25 culture flasks; for suspension cultures, transfer all the medium into one T25 flask to promote effective cell interaction and growth.
Adhere to established subculture protocols for continued growth and maintenance of the cell line, ensuring reliable experimental outcomes.
07Quality control and cryopreservation
- Sterility
Mycoplasma contamination is excluded using both PCR-based assays and luminescence-based mycoplasma detection methods.
To ensure there is no bacterial, fungal, or yeast contamination, cell cultures are subjected to daily visual inspections.
- Freeze medium
- As a cryopreservation medium, we use complete growth medium (including FBS) + 10% DMSO for adequate post-thaw viability, or CM-1 (Cytion catalog number 800100), which includes optimized osmoprotectants and metabolic stabilizers to enhance recovery and reduce cryo-induced stress.
- Storage conditions
For long-term preservation, place vials in vapor-phase liquid nitrogen at about −150 to −196 °C. Storage at −80 °C is acceptable only as a short interim step before transfer to liquid nitrogen.
- Shipping conditions
Cryopreserved cell lines are shipped on dry ice in validated, insulated packaging with sufficient refrigerant to maintain approximately −78 °C throughout transit. On receipt, inspect the container immediately and transfer vials without delay to appropriate storage.
08Donor
- Breed / subspecies
- Sprague-Dawley
- Donor age
- Age unspecified
- Ethnicity
- Not applicable (rat cell line; Sprague-Dawley in Q)
09Legal and safety
- Safety precautions
- When planning to store a cryovial in liquid nitrogen for future thawing, it is mandatory to adhere to stringent safety measures. Appropriate protective gloves and clothing are essential, and the use of a face mask or safety goggles is required during the transfer of frozen samples to or from the liquid nitrogen tank. This is to mitigate the risk of injury from potential cryovial explosions upon removal, which can result in the projection of sharp fragments.
- Disclaimer
- Our cells are provided for in vitro laboratory research purposes exclusively and are not intended for clinical or diagnostic use, nor are they to be administered to humans or used for veterinary purposes. Users must adhere to all applicable guidelines and regulations for the handling and use of these cells in a research setting.
- Warranty
At Cytion, we stand behind the quality and viability of our products. We guarantee that our cells will be viable at the start of culture for 60 days after shipment from our facilities. We assure that all materials conform to the specifications described in the Certificate of Analysis and/or Product Sheet.
For full details, please refer to our Warranty Statement.
- Material Transfer Agreement required
- Yes